Learning Session 6: Addressing Barriers to Change: The Perspective of Psychiatry, Nursing and Medical Directors
In this final session, all previous presenters (geriatric psychiatrist, nurse practitioner, and medical director) return to discuss common barriers they face when trying to reduce antipsychotic medication usage as well as provide helpful advice for how to work through these challenges.
Objectives:
- To discuss the benefits of and barriers to reducing antipsychotic medications as identified by focus group participants
- To identify and address barriers encountered by each profession
Presenters:
Paul Newhouse, MD
Warren Taylor, MD
James Powers, MD
Ralf Habermann, MD
Jennifer Kim, DNP, GNP-BC
Available Webinars:
Learning Session 1:
Introduction to Dementia Care and Quality Assessment and Performance Improvement
Learning Session 2:
Understanding Dementia and the Nature of Behavioral Disturbances
Learning Session 3:
Psycho-pharmacology in the Long-Term Care Setting
Learning Session 4:
Principles of Non-Pharmacologic Management and the Formulation of Behavioral Care Plans
Learning Session 5:
The Implementation of Behavioral Care Plans and the Management of Pharmacological Approaches
Learning Session 6:
Addressing Barriers to Change: The Perspective of Psychiatry, Nursing and Medical Directors
Access Materials from This Session